# Venrock Adviser, LLC 13F holdings Q2 2026: $3.3 billion

Venrock Adviser, LLC reported $3.3 billion in 13F securities across 33 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Apogee Therapeutics Inc at $1.1 billion, 34.2% of the reported value. Since Q1 2026 it opened 4 new positions and exited 4.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $3,298,051,614
- Positions: 33
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1615982
- Form 13F file number: 028-20281
- CRD number: 169288
- Business address: 7 Bryant Park 23rd Floor, New York, NY 10018
- SEC filing: [0001615982-26-000015](https://www.sec.gov/Archives/edgar/data/1615982/000161598226000015/0001615982-26-000015-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/venrock-adviser-llc-169288)

## Top 25 holdings by value

The largest of 33 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 8,493,321 | $1.13 billion | No change |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 4,148,428 | $394.8 million | No change |
| [Erasca Inc](https://specstream.ai/data/institutional-holders/erasca-inc-29479a108) | COM | 17,891,812 | $327.8 million | +1,509,000 |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 2,985,448 | $265 million | -700,000 |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 1,180,000 | $115 million | No change |
| [Ocular Therapeutix Inc](https://specstream.ai/data/institutional-holders/ocular-therapeutix-inc-67576a100) | COM | 10,346,926 | $101.6 million | No change |
| [Damora Therapeutics Inc](https://specstream.ai/data/institutional-holders/damora-therapeutics-inc-36322q206) | COM NEW | 3,603,595 | $93.7 million | No change |
| [Savara Inc](https://specstream.ai/data/institutional-holders/savara-inc-805111101) | COM | 14,745,943 | $90.8 million | +1,005,568 |
| [Jade Biosciences Inc](https://specstream.ai/data/institutional-holders/jade-biosciences-inc-008064206) | COM NEW | 3,220,364 | $71.6 million | No change |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 1,642,166 | $63.6 million | -357,834 |
| [Viridian Therapeutics Inc](https://specstream.ai/data/institutional-holders/viridian-therapeutics-inc-92790c104) | COM | 3,257,917 | $59.8 million | -624,792 |
| [Vor Biopharma Inc](https://specstream.ai/data/institutional-holders/vor-biopharma-inc-929033207) | COM NEW | 3,041,719 | $56 million | No change |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 2,173,913 | $48.3 million | No change |
| [Maze Therapeutics Inc](https://specstream.ai/data/institutional-holders/maze-therapeutics-inc-578784100) | COM | 1,602,034 | $47.8 million | No change |
| [Relmada Therapeutics Inc](https://specstream.ai/data/institutional-holders/relmada-therapeutics-inc-75955j402) | COM | 6,844,305 | $47.4 million | +2,000,925 |
| [Oric Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/oric-pharmaceuticals-inc-68622p109) | COM | 4,319,765 | $46.8 million | No change |
| [Crescent Biopharma Inc.](https://specstream.ai/data/institutional-holders/crescent-biopharma-inc-g2545c104) | COM | 2,133,576 | $38.4 million | No change |
| [Zura Bio LTD](https://specstream.ai/data/institutional-holders/zura-bio-ltd-g9ty5a101) | CLASS A ORD SHS | 6,434,990 | $38 million | No change |
| [Adlai Nortye LTD](https://specstream.ai/data/institutional-holders/adlai-nortye-ltd-00704r109) | SPONSORED ADS | 3,212,731 | $36.9 million | No change |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 526,331 | $26.7 million | -1,200,000 |
| [Cybin Inc](https://specstream.ai/data/institutional-holders/cybin-inc-23256x407) | COM NEW | 3,851,654 | $25.5 million | No change |
| [Cullinan Therapeutics Inc](https://specstream.ai/data/institutional-holders/cullinan-therapeutics-inc-230031106) | COM | 1,379,965 | $25.1 million | No change |
| [Century Therapeutics Inc](https://specstream.ai/data/institutional-holders/century-therapeutics-inc-15673t100) | COM | 8,695,652 | $21.3 million | No change |
| [Artiva Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/artiva-biotherapeutics-inc-04317a107) | COM | 2,043,596 | $19.8 million | +434,027 |
| [Cytomx Therapeutics Inc.](https://specstream.ai/data/institutional-holders/cytomx-therapeutics-inc-23284f105) | COM | 4,982,124 | $18.7 million | -5,000,000 |

## New positions in Q2 2026

4 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Achieve Life Science Inc](https://specstream.ai/data/institutional-holders/achieve-life-science-inc-004468500) | COM | 2,751,032 | $18 million |
| [Parabilis Medicines Inc](https://specstream.ai/data/institutional-holders/parabilis-medicines-inc-698955101) | COM | 625,000 | $17.1 million |
| [Research Alliance Corp III](https://specstream.ai/data/institutional-holders/research-alliance-corp-iii-g75226103) | ORD SHS CL A | 300,000 | $3.2 million |
| [Inmed Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/inmed-pharmaceuticals-inc-457637700) | COM NEW | 32,685 | $50,662 |

## Positions exited in Q2 2026

4 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Kalvista Pharmaceuticals Inc | COM | 6,474,485 | $130.3 million |
| Engene Holdings Inc | COM | 4,771,414 | $32.5 million |
| [Tenax Therapeutics Inc](https://specstream.ai/data/institutional-holders/tenax-therapeutics-inc-88032l605) | COM NEW | 1,675,262 | $26.8 million |
| [Septerna Inc](https://specstream.ai/data/institutional-holders/septerna-inc-81734d104) | COM | 506,056 | $12.2 million |

## Also on SpecStream

- [Venrock Adviser, LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1615982/000161598226000015/0001615982-26-000015-index.htm)
- [Venrock Adviser, LLC investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/venrock-adviser-llc-169288)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Escrow companies in New York, New York](https://specstream.ai/data/businesses/escrow-companies/new-york-new-york-united-states)
- [Fast food restaurants in New York, New York](https://specstream.ai/data/businesses/fast-food-restaurants/new-york-new-york-united-states)
- [Freight and cargo companies in New York, New York](https://specstream.ai/data/businesses/freight-and-cargo-companies/new-york-new-york-united-states)
- [General dentistry practices in New York, New York](https://specstream.ai/data/businesses/general-dentistry-practices/new-york-new-york-united-states)
- [Handyman services in New York, New York](https://specstream.ai/data/businesses/handyman-services/new-york-new-york-united-states)
- [Home inspectors in New York, New York](https://specstream.ai/data/businesses/home-inspectors/new-york-new-york-united-states)
